“Complex Regional Pain Syndrome Epidemiology” report has been recently added to DelveInsight
About Complex Regional Pain Syndrome
Complex regional pain syndrome (CRPS) is defined as a “painful syndrome, which includes regional pain, sensory changes (e.g. allodynia), abnormalities of temperature, abnormal sudomotor activity, edema and an abnormal skin color that occurs after an initiating noxious event such as trauma etc.” CRPS may develop after major trauma, surgery, or minor injury, and progresses with a variable course that ranges from self-limiting, mild symptomatology to chronic disease.
Request for free sample copy of CRPS epidemiology report- https://www.delveinsight.com/sample-request/complex-regional-pain-syndrome-epidemiology-forecast
Complex Regional Pain Syndrome Epidemiology
“CRPS-I is a syndrome characterized by a continuing (spontaneous and/or evoked) regional pain that is seemingly disproportionate in time or degree to the usual course of pain after trauma or another lesion. The pain is regional (not in a specific nerve territory or dermatome) and usually has a distal predominance of abnormal sensory, motor, sudomotor, vasomotor/edema and/or trophic findings. The syndrome shows variable progression over time. CRPS-I occurs after any form of trauma, particularly a fracture or soft tissue lesion. CRPS-II occurs after nerve damage.”
Important key facts of Complex Regional Pain Syndrome epidemiology report
Complex Regional Pain Syndrome epidemiology segmentation
Complex Regional Pain Syndrome Treatment
Currently, the treatment of CRPS is restricted to palliative care and symptom-based interventions such as Non-opioid analgesics (Paracetamol, NSAIDs, Nefopam etc.), Weak opioid analgesics (Tramadol, Codeine/Acetaminophen, Opium/PCM etc.), Strong opioid analgesics, Co-analgesics (Corticosteroids, Antiepileptics, Antidepressants, Tricyclic Antidepressants, SNRIs, Bisphosphonate, IV Bisphosphonate, Calcitonin, Ketamine etc.), Local treatment (Joint infusion of corticosteroids, Lidocaine cream, Lidocaine patch, Capsaicin, NSAIDs etc.) and others (including Physiotherapy, surgery, Psychological interventions etc.). Currently, Neridronate is the only first line drug that has showed its efficacy in CRPS patients and available in the Italy market. It is the only therapy approved for the treatment of CRPS in Italy (Abiogen Pharma).
Complex Regional Pain Syndrome Epidemiology: Report Highlights
Following is the table of content of Complex Regional Pain Syndrome Epidemiology Report
1. Key Insights
2. Executive Summary of Complex Regional Pain Syndrome (CRPS)
3. Complex Regional Pain Syndrome (CRPS): Disease Background and Overview
5. Appendix
6. DelveInsight Capabilities
7. Disclaimer
8. About DelveInsight
What are the important reasons to buy?
Related Report
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Yash BhardwajEmail: Send EmailPhone: +919650213330Address:304 S. Jones Blvd #2432 City: Las VegasState: NVCountry: United StatesWebsite: https://www.delveinsight.com/